Detalles de la búsqueda
1.
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study.
Ann Hematol
; 103(3): 803-811, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950052
2.
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.
Cancer
; 129(24): 3905-3914, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572086
3.
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtime.
Hematol Oncol
; 41(5): 838-847, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403752
4.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314897
5.
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Ann Hematol
; 102(8): 2127-2136, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335322
6.
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.
Eur J Haematol
; 110(2): 149-156, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251268
7.
Chimeric antigen receptor T-cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis.
Br J Haematol
; 198(5): 838-846, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35765220
8.
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies.
Haematologica
; 107(3): 715-720, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320790
9.
Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study.
Haematologica
; 107(5): 1111-1118, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34233446
10.
Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.
Eur J Nucl Med Mol Imaging
; 49(7): 2290-2299, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35079846
11.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Ann Hematol
; 101(4): 755-762, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083525
12.
Obinutuzumab-related adverse events: A systematic review and meta-analysis.
Hematol Oncol
; 39(2): 215-221, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33252145
13.
R-CHOP compared to R-CHOP + X for newly diagnosed diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Acta Oncol
; 60(6): 744-749, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33734921
14.
Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis.
Acta Oncol
; 60(10): 1335-1341, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34325602
15.
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma.
Future Oncol
; 17(11): 1295-1310, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33528286
16.
Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies.
Hematol Oncol
; 38(4): 584-588, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32506594
17.
Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia - an updated meta-analysis.
Br J Haematol
; 186(2): 234-242, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30980398
18.
The role of maintenance therapy in patients with diffuse large B cell lymphoma: A systematic review and meta-analysis.
Hematol Oncol
; 37(1): 27-34, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30216478
19.
FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.
Hematol Oncol
; 37(2): 168-175, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30734341
20.
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
Hematol Oncol
; 37(5): 569-577, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31674027